跳至主要内容
临床试验/NCT05617690
NCT05617690招募中不适用

Effect of Cyclopol on Intraoperative Electrophysiological Monitoring in Spine Surgery: A Randomized Controlled, Noninferiority Study

Beijing Tiantan Hospital1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2023年4月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
148
试验地点
1
主要终点
N75-p100 amplitude of FVEP

研究概览

简要总结

Postoperative visual function injury occurs after spinal cord, neurosurgery, ophthalmology and other operations, which directly affects the postoperative quality of life of patients. Flash visual evoked potential (FVEP) is important for evaluating visual function under general anesthesia during operation. The changes of visual function can be observed and recognized in time through the amplitude changes of FVEP, which can avoid or reduce the visual function damage during operation. Anesthesia method determines the success and variability of electrophysiological monitoring to a certain extent. The purpose of this study is to investigate the effect of total intravenous anesthesia based on cyclopol on FVEP compared with propofol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing elective spinal surgery under general anesthesia;
  • Intraoperative electrophysiological monitoring is required;
  • 18-65 years old;
  • Sign the informed consent.

排除标准

  • Patients with visual impairment;
  • Patients with severe liver or kidney disease;
  • Uncontrolled hypertension, diabetes, severe arrhythmia or unstable angina pectoris;
  • Have mental illness or unable to communicate;
  • BMI≥30kg/㎡;
  • Abuse of analgesics and drug abuse history;
  • Muscle weakness, motor dysfunction or neuromuscular junction disease before operation;
  • Preoperative somatosensory dysfunction;
  • Retain trachea catheter after operation;
  • Narcotic drugs and silicone allergy;
  • Visual evoked potential monitoring was rejected.

研究组 & 干预措施

Cyclopol group

Experimental

干预措施: Cyclopol (Drug)

Propofol group

Active Comparator

干预措施: Propofol (Drug)

结局指标

主要结局

N75-p100 amplitude of FVEP

时间窗: Intraoperative

次要结局

未报告次要终点

研究者

发起方
Beijing Tiantan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ruquan Han

Professor

Beijing Tiantan Hospital

研究点 (1)

Loading locations...

相似试验